Evidence map›Paper›PMID 41192422›Full record

ArticleCell2025

Disparate leukemia mutations converge on nuclear phase-separated condensates.

Gandhar K Datar, Elmira Khabusheva, Archish Anand, Joshua Beale, Marwa Sadek, Chun-Wei Chen, Evdokiia Potolitsyna, Nayara Alcantara-Contessoto, Guangyuan Liu, Josephine De La Fuente and 15 more

Abstract read
In one paragraph

Article in Cell, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. A unified photosensitizer platform forbioRxiv : the preprint server for biology · 2026
    Article
  12. Article
  13. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

25 authors.

Gandhar K DatarMedical Scientist Training Program, Baylor College of Medicine, Houston, TX 77030, USA; Cancer and Cell Biology Graduate Program, Baylor College of Medicine, Houston, TX 77030, USA; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA; Stem Cells and Regenerative Medicine Center, Baylor College of Medicine, Houston, TX 77030, USA.
Elmira KhabushevaDepartment of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA; Stem Cells and Regenerative Medicine Center, Baylor College of Medicine, Houston, TX 77030, USA.
Archish AnandDepartment of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA.
Joshua BealeDepartment of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA; Stem Cells and Regenerative Medicine Center, Baylor College of Medicine, Houston, TX 77030, USA.
Marwa SadekDepartment of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA; Stem Cells and Regenerative Medicine Center, Baylor College of Medicine, Houston, TX 77030, USA; Diagnostic Genetics and Genomics Program, School of Health Professions, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Chun-Wei ChenDepartment of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA; Stem Cells and Regenerative Medicine Center, Baylor College of Medicine, Houston, TX 77030, USA.
Evdokiia PotolitsynaDepartment of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA.
Nayara Alcantara-ContessotoDepartment of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA.
Guangyuan LiuDepartment of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA; Stem Cells and Regenerative Medicine Center, Baylor College of Medicine, Houston, TX 77030, USA.
Josephine De La FuenteDepartment of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA; Stem Cells and Regenerative Medicine Center, Baylor College of Medicine, Houston, TX 77030, USA.
Christina DollingerDepartment of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA.
Anna GuzmanDepartment of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA; Stem Cells and Regenerative Medicine Center, Baylor College of Medicine, Houston, TX 77030, USA.
Alejandra MartellDepartment of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA; Stem Cells and Regenerative Medicine Center, Baylor College of Medicine, Houston, TX 77030, USA.
Katharina WohlanDepartment of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA; Stem Cells and Regenerative Medicine Center, Baylor College of Medicine, Houston, TX 77030, USA.
Abhishek MaitiDepartment of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Nicholas J ShortDepartment of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
S Stephen YiBaylor Research Institute and School of Medicine, Baylor College of Medicine, Temple, TX 76508, USA.
Vibeke AndresenK.G. Jebsen Centre for Myeloid Blood Cancer, Department of Clinical Science, University of Bergen, Bergen 5021, Norway; Centre of Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, Bergen 5021, Norway.
Bjørn Tore GjertsenK.G. Jebsen Centre for Myeloid Blood Cancer, Department of Clinical Science, University of Bergen, Bergen 5021, Norway; Centre of Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, Bergen 5021, Norway; Department of Medicine, Hematology Section, Haukeland University Hospital, Bergen 5021, Norway.
Brunangelo FaliniInstitute of Hematology and Center for Hemato-Oncological research (CREO), University of Perugia and Santa Maria della Misericordia Hospital, Perugia 06123, Italy.
Rachel E RauBen Towne Center for Childhood Cancer Research, Seattle Children's Research Institute, Department of Pediatrics, University of Washington School of Medicine, Seattle, WA 98195, USA.
Lorenzo BrunettiDepartment of Molecular and Clinical Sciences, Università Politecnica delle Marche, Ancona 60126, Italy.
Nidhi SahniDepartment of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Quantitative and Computational Biosciences Program, Baylor College of Medicine, Houston, TX 77030, USA.
Margaret A GoodellDepartment of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA; Stem Cells and Regenerative Medicine Center, Baylor College of Medicine, Houston, TX 77030, USA. Electronic address: goodell@bcm.edu.
Joshua A RibackDepartment of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA. Electronic address: josh.riback@bcm.edu.

Funding

Tumor BiologyP30CA125123 · NCI · BAYLOR COLLEGE OF MEDICINE · PI Suzanne AW Fuqua · 2007 to 2026
$73.9M
PEDIATRIC ONCOLOGY CLINICAL RESEARCH TRAINING PROGRAMK12CA090433 · NCI · BAYLOR COLLEGE OF MEDICINE · PI CARL E ALLEN, Donald W. Parsons · 2002 to 2026
$18.5M
Project 3: Contribution of inflammation and DNA damaging factors to clonal expansion and malignant transformation in a community cohort of older adultsP01CA265748 · NCI · BAYLOR COLLEGE OF MEDICINE · PI Koichi Takahashi · 2022 to 2026
$13.6M
DNMT3A in Development of Hematologic MalignanciesR01CA183252 · NCI · BAYLOR COLLEGE OF MEDICINE · PI MARGARET A. GOODELL · 2014 to 2026
$7.1M
Training In Cell and Gene TherapyT32HL092332 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI MALCOLM K. BRENNER, Bruno Di Stefano · 2008 to 2026
$6.9M
DEFINING THE ROLE OF DOT1L IN DNMT3A-MUTANT LEUKEMIAK08CA201611 · NCI · BAYLOR COLLEGE OF MEDICINE · PI RAU, RACHEL E · 2017 to 2019
$486k
BD Biosciences Special Order LSRIIS10RR024574 · NCRR · BAYLOR COLLEGE OF MEDICINE · PI LUMPKIN, ELLEN A · 2009 to 2009
$430k
Defining the Synergistic Role of NPM1 and DNMT3A Mutations on HOX Gene Regulation in the Pathogenesis of Acute Myeloid LeukemiaF30CA268725 · NCI · BAYLOR COLLEGE OF MEDICINE · PI DATAR, GANDHAR KIRAN · 2022 to 2023
$98k
NCI NIH HHS F30 CA268725NCI NIH HHS K08 CA201611NCI NIH HHS K12 CA090433NCI NIH HHS P01 CA265748NCI NIH HHS P30 CA125123NCI NIH HHS R01 CA183252NCRR NIH HHS S10 RR024574NHLBI NIH HHS T32 HL092332
6 · The paper itself

Abstract

During cancer development, mutations promote changes in gene expression that cause transformation. Leukemia associated with aberrant HOXA expression is driven by translocations of nucleoporin genes or KMT2A as well as mutations in NPM1. The mechanistic convergence of these disparate mutations remains elusive. Here, we demonstrate that mutant nucleophosmin 1 (NPM1c) forms nuclear condensates in human cell lines, mouse models, and primary patient samples. We show NPM1c phase separation is necessary and sufficient to recruit NUP98 and KMT2A to condensates. Through extensive mutagenesis and pharmacological destabilization of phase separation, we find that NPM1c condensates are necessary for regulating gene expression, promoting in vivo leukemic expansion, and maintaining the undifferentiated leukemic state. Finally, we show that nucleoporin and KMT2A fusion proteins form condensates that are biophysically indistinguishable from NPM1c condensates. Together, these data define a new condensate that we term the coordinating body (C-body) and establish C-bodies as a therapeutic vulnerability in leukemia.

Indexed as

LeukemiaNuclear ProteinsAnimalsCell Line, TumorCell NucleusHistone-Lysine N-MethyltransferaseHumansMiceMutationMyeloid-Lymphoid Leukemia ProteinNuclear Pore Complex ProteinsNucleophosminHistone-Lysine N-MethyltransferaseKMT2A protein, humanMyeloid-Lymphoid Leukemia ProteinNPM1 protein, humanNpm1 protein, mouseNuclear Pore Complex ProteinsNuclear ProteinsNucleophosminNup98 protein, humanacute myeloid leukemiaAMLcondensateHOXKMT2AMENINNPM1NUP98phase separationXPO1

Identifiers

PMID41192422
PMCPMC12773745

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.